People: NPS Pharmaceuticals Inc (NPSP.OQ)
14.91USD
24 May 2013
$-0.34 (-2.23%)
$15.25
$15.22
$15.22
$14.71
329,106
552,550
$16.36
$6.62
Beshar, Luke
Brief Biography
Mr. Luke M. Beshar, CPA, is Chief Financial Officer, Executive Vice President of NPS Pharmaceuticals, Inc. He joined NPS in November 2007. He is a former Chief Financial Officer of various public and private companies and has more than 25 years of general and financial management experience. Prior to joining NPS, he served as Executive Vice President and Chief Financial Officer of Cambrex Corporation from December 2002 to November 2007, a global life sciences company, and Senior Vice President and Chief Financial Officer at Dendrite International from January 2002 to December 2002. Mr. Beshar began his career with Arthur Andersen & Co. in 1980 and is a Certified Public Accountant. Mr. Beshar obtained his B.S. degree in Accounting and Finance from Michigan State University and is a graduate of The Executive Program at the Darden Graduate School of Business at the University of Virginia.
Basic Compensation
| Total Annual Compensation, USD | Long-Term Incentive Plans, USD | All Other, USD | Fiscal Year Total, USD |
|---|---|---|---|
| 613,380 | -- | 245,857 | 1,080,090 |
Options Compensation
| Quantity | Market Value | |
|---|---|---|
| Excercisable | -- | -- |
| Unexercisable | -- | -- |
| Excercised | -- | -- |
| Name | Fiscal Year Total |
|---|---|
Peter Tombros |
-- |
Francois Nader |
2,622,650 |
Luke Beshar |
1,080,090 |
Edward Stratemeier |
707,419 |
Glenn Melrose |
-- |
Roger Garceau |
1,132,650 |

